Feds May Tighten Rules on Omniscan, a GE MRI Drug

by Jeff Gerth
ProPublica, Dec. 2, 2009, 6:55 p.m.

An FDA review says MRI imaging drugs may be even riskier for kidney patients than it believed previously.

FDA to Take a Second Look at Warnings on MRI Drugs

by Jeff Gerth
ProPublica, Oct. 16, 2009, 3:37 p.m.

After issuing a blanket warning about the risk to patients with kidney disease, regulators will reconsider whether to treat some imaging agents differently.

How Three University Medical Centers Handled GE’s Omniscan

by Jeff Gerth
ProPublica, Oct. 15, 2009, 5:14 p.m.

While GE Healthcare argued against special regulatory restrictions on Omniscan, doctors at three prominent U.S. medical centers moved away from the drug on their own.